Emerging Trends within Cell & Gene Manufacturing
The level of process efficiency behind today’s cell and gene therapies is said to rest at a low. The manufacturing behind them is mostly manual, due to the treatments mostly being within early development stages. There are, however, some cases where companies utilise partly automated solutions.In regards to the progress required behind this market in regards to process excellence, Elena Meurer, Head of Pharmaceutical and Technical Development at apceth GmbH & Co.KG sees t...
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.